Related Experiment Videos
Proinflammatory cytokines and skeletal muscle
Ulrike Späte1, P Christian Schulze
1The Forsyth Institute, Department of Cytokine Biology, Boston, Massachusetts, USA.
Current Opinion in Clinical Nutrition and Metabolic Care
|April 13, 2004
Summary
Proinflammatory cytokines drive muscle wasting in chronic diseases by promoting protein breakdown and suppressing growth factors. Understanding these molecular pathways offers new therapeutic targets for muscular atrophy.
Area of Science:
- Biochemistry
- Molecular Biology
- Physiology
Background:
- Chronic diseases often lead to metabolic abnormalities and muscle wasting.
- Proinflammatory cytokines are implicated in inducing and mediating catabolic mechanisms.
- Understanding these processes is crucial for managing muscle loss in chronic conditions.
Purpose of the Study:
- To review the role of proinflammatory cytokines in muscle atrophy.
- To discuss molecular signaling pathways and transcriptional regulation in muscle wasting.
- To identify cellular systems contributing to enhanced muscle protein breakdown.
Main Methods:
- Review of scientific literature.
- Analysis of transcriptional screening techniques.
- Examination of molecular signaling pathways and gene expression.
Main Results:
- Identified specific gene expression changes in muscle wasting.
- Highlighted the role of E3 ligases (e.g., atrogin-1) in ubiquitin-proteasome pathway activation.
- Noted the involvement of transcription factors like nuclear factor kappa B in inflammation and atrophy.
- Demonstrated suppression of insulin-like growth factor 1 by proinflammatory cytokines.
Conclusions:
- Proinflammatory cytokines significantly contribute to skeletal muscle atrophy in chronic diseases.
- Research has elucidated molecular pathways underlying muscle wasting.
- New molecular targets for treating muscular atrophy are emerging.